X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1140) 1140
male (815) 815
angiotensin-converting enzyme inhibitors - therapeutic use (813) 813
perindopril - therapeutic use (777) 777
perindopril (684) 684
hypertension - drug therapy (661) 661
female (632) 632
middle aged (584) 584
antihypertensive agents - therapeutic use (532) 532
aged (479) 479
blood pressure - drug effects (419) 419
hypertension (399) 399
treatment outcome (313) 313
adult (290) 290
cardiac & cardiovascular systems (263) 263
indoles - therapeutic use (253) 253
animals (251) 251
drug therapy, combination (243) 243
hypertension - physiopathology (230) 230
indapamide - therapeutic use (230) 230
pharmacology & pharmacy (223) 223
double-blind method (219) 219
blood-pressure (202) 202
peripheral vascular disease (195) 195
angiotensin-converting enzyme inhibitors - pharmacology (190) 190
rats (188) 188
blood pressure (185) 185
perindopril - administration & dosage (166) 166
hypertension - complications (162) 162
risk factors (159) 159
randomized controlled trials as topic (145) 145
perindopril - pharmacology (143) 143
ace inhibitors (139) 139
drug combinations (131) 131
mortality (128) 128
angiotensin-converting enzyme inhibitors - administration & dosage (127) 127
diuretics - therapeutic use (124) 124
medicine, general & internal (123) 123
time factors (123) 123
aged, 80 and over (120) 120
drug therapy (109) 109
risk (108) 108
antihypertensive agents - administration & dosage (106) 106
cardiovascular events (106) 106
follow-up studies (104) 104
prevention (104) 104
angiotensin (103) 103
perindopril - adverse effects (102) 102
stroke - prevention & control (102) 102
stroke (96) 96
angiotensin-converting enzyme inhibitors - adverse effects (94) 94
antihypertensive agents - adverse effects (93) 93
medicine & public health (91) 91
indapamide (90) 90
dose-response relationship, drug (89) 89
amlodipine - therapeutic use (88) 88
captopril (88) 88
trial (88) 88
antihypertensive agents - pharmacology (87) 87
heart failure - drug therapy (85) 85
clinical trials as topic (84) 84
prospective studies (81) 81
enalapril (80) 80
indapamide - administration & dosage (75) 75
amlodipine (71) 71
cardiovascular diseases - prevention & control (71) 71
diabetes mellitus, type 2 - complications (71) 71
therapy (71) 71
indoles - pharmacology (70) 70
cardiovascular disease (69) 69
analysis (68) 68
cardiology (68) 68
disease (68) 68
enzymes (68) 68
angiotensin-converting enzyme inhibitors (66) 66
care and treatment (66) 66
internal medicine (66) 66
double-blind (65) 65
atenolol - therapeutic use (62) 62
myocardial-infarction (61) 61
rats, inbred shr (61) 61
research (61) 61
diabetes mellitus, type 2 - drug therapy (60) 60
renin-angiotensin system - drug effects (60) 60
calcium channel blockers - therapeutic use (58) 58
echocardiography (58) 58
diabetes (57) 57
outcomes (55) 55
adrenergic beta-antagonists - therapeutic use (53) 53
clinical trials (53) 53
heart failure (53) 53
management (53) 53
secondary prevention (53) 53
adolescent (51) 51
health aspects (51) 51
renin-angiotensin system (51) 51
dosage and administration (50) 50
enalapril - therapeutic use (50) 50
heart rate - drug effects (50) 50
pharmacology/toxicology (50) 50
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1175) 1175
Russian (115) 115
French (50) 50
German (23) 23
Chinese (19) 19
Japanese (10) 10
Spanish (7) 7
Italian (6) 6
Hungarian (5) 5
Ukrainian (5) 5
Czech (4) 4
Danish (4) 4
Polish (3) 3
Croatian (1) 1
Dutch (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2018, Volume 2020, Issue 2, p. CD009068
...‐linked dilated cardiomyopathy (XLDCM). In recent years, co‐ordinated multidisciplinary management for these diseases has improved the quality of care, with early corticosteroid use prolonging independent ambulation, and the routine use of non... 
Muscle Diseases | Becker muscular dystrophy | Neurology | Duchenne muscular dystrophy | Prevention and treatment for cardiac complications in Becker muscular dystrophy | Child health | Muscular dystrophies | Prevention and treatment for cardiac complications in Duchenne muscular dystrophy | Muscle disease | Medicine General & Introductory Medical Sciences | VENTRICULAR SYSTOLIC DYSFUNCTION | ECHOCARDIOGRAPHIC MEASURES | MEDICINE, GENERAL & INTERNAL | RESYNCHRONIZATION THERAPY | ABNORMALITIES | IMPLANTATION | INVOLVEMENT | DISEASE | MUSCLE | CONGESTIVE-HEART-FAILURE | CARRIERS | Humans | Cardiomyopathies - prevention & control | Male | Cardiomyopathies - etiology | Young Adult | Human Growth Hormone - therapeutic use | Placebos - therapeutic use | Lisinopril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Placebos - adverse effects | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Non-Randomized Controlled Trials as Topic | Ubiquinone - therapeutic use | Adult | Ubiquinone - adverse effects | Child | Cardiomyopathies - drug therapy | Cardiomyopathy, Dilated - complications | Eplerenone - therapeutic use | Ubiquinone - analogs & derivatives | Stroke Volume - drug effects | Eplerenone - adverse effects | Antihypertensive Agents - therapeutic use | Muscular Dystrophy, Duchenne - complications | Disease Progression | Randomized Controlled Trials as Topic | Cardiovascular Agents - therapeutic use | Adolescent | Losartan - therapeutic use | Perindopril - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Angiotensin Receptor Antagonists - adverse effects
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2009, Volume 54, Issue 13, pp. 1154 - 1161
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2008, Volume 358, Issue 18, pp. 1887 - 1898
Journal Article
Diabetes care, ISSN 1935-5548, 2009, Volume 32, Issue 11, pp. 2068 - 2074
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 03/2006, Volume 113, Issue 9, pp. 1213 - 1225
Journal Article
Journal Article
Trials, ISSN 1745-6215, 2019, Volume 20, Issue 1, pp. 389 - 9
Background: Hypertension is an important risk factor for cardiovascular disease, even in the elderly. Fimasartan is a new non-peptide angiotensin II receptor... 
Hypertension | MEDICINE, RESEARCH & EXPERIMENTAL | Essential hypertension | MULTICENTER | Frail elderly | CLINICAL-TRIAL | EFFICACY | PHASE-III | KOREAN PATIENTS | FRAILTY | AMLODIPINE | Treatment | PARALLEL-GROUP | Fimasartan | DOUBLE-BLIND | Perindopril | Elderly | AGE | Angiotensin II Type 1 Receptor Blockers - adverse effects | Age Factors | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Biphenyl Compounds - adverse effects | Male | Biphenyl Compounds - therapeutic use | Essential Hypertension - drug therapy | Essential Hypertension - diagnosis | Clinical Trials, Phase III as Topic | Multicenter Studies as Topic | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Time Factors | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Aged, 80 and over | Female | Blood Pressure - drug effects | Drug Therapy, Combination | Equivalence Trials as Topic | Republic of Korea | Double-Blind Method | Treatment Outcome | Antihypertensive Agents - therapeutic use | Essential Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Perindopril - adverse effects | Diuretics - therapeutic use | Tetrazoles - therapeutic use | Aged | Tetrazoles - adverse effects | Perindopril - therapeutic use | Diuretics - adverse effects | Aged patients | Dosage and administration | Drug therapy | Comparative analysis | Angiotensin II receptor blockers
Journal Article
Journal Article